Nachrichten zur Moderna Inc. Aktie

Moderna Has Lost 94% Of Its Value Over Four Years. Is It A Sell?

Shares hit another skid on Jan. 13 when the company cut its guidance for 2024 and 2025.…

Stocks rise as investors eye inflation data: Yahoo Finance

All three of the major indexes are moving higher. Investors have been watching inflation reports closely, including the December PPI…

Stock Market Today: Dow, S&P 500, Nasdaq Set to Open Up, Trump Tariffs, Treasury Yields Fall; Moderna, Nvidia, Palantir, More Movers

Dow, S&P 500, and Nasdaq futures are rising in premarket trading Tuesday as the stock market digests a report on…

Märkte am Morgen: Warten auf Konjunkturdaten; D-Wave, Edison, Munich Re, Bitcoin, Nel, Moderna, Daimler Truck, Abercombie

Zum Wochenauftakt schloss der DAX 0,41 Prozent tiefer bei 20.132 Punkten. Heute steht der Leitindex vor Herausforderungen durch gemischte Vorgaben…

Moderna Stock Plummets 17% on 2025 Sales Guidance Slash

The crash in MRNA stock comes after the company slashed its outlook for 2024 and 2025 sales and also announced…

Stocks making the biggest moves midday: Nvidia, quantum computing stocks, Moderna and more

These are the stocks posting the largest moves in midday trading.…

Why Moderna Stock Just Crashed 21%

Modernas (NASDAQ: MRNA) sales are slowing down, and Moderna stock is going down -- a lot. The coronavirus vaccine makers shares…

These Stocks Are Moving the Most Today: Nvidia, Tesla, Moderna, Intra-Cellular Therapies, D-Wave Quantum, Edison, U.S. Steel, and More

…

Moderna cuts sales forecast on weaker vaccine demand

…

Investoren meiden heute die Moderna-Aktie: Kurs gibt deutlich nach (31,925 €)

Keinen Grund zur Freude haben Inhaber dem Anteilsschein von Moderna : Der Kurs des Papiers sackt kräftig ab. Jahreschart der…

Moderna Aktie: Nächste Hiobsbotschaft

Kulmbach (www.aktiencheck.de) - Moderna-Aktienanalyse von "Der Aktionär": Thomas Bergmann vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Moderna stock plunges 20% after company lowers 2025 sales forecast by $1 billion

Moderna now expects 2025 revenue to come in between $1.5 billion and $2.5 billion, most of which will come in…

Moderna slashes 2025 sales forecast, shares sink

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares plunged almost 20% after the drugmaker pre-announced fiscal 2024 sales below expectations. The company expects...…

Pharma: Moderna kürzt Prognose und plant Kostensenkungen – Aktie bricht ein

Das Unternehmen korrigiert seine Prognose um eine Milliarde Dollar. Grund dafür sind Probleme im Impfstoff-Geschäft. Die Moderna-Aktie gibt am Montag…

Moderna adjusts 2025 revenue outlook, shares fall By Investing.com

Moderna adjusts 2025 revenue outlook, shares fall…

Moderna cuts 2025 sales forecast by $1 billion on weak vaccine demand, shares fall

…

Moderna cuts 2025 sales view on slow start to RSV shot, weak COVID vaccine demand

Moderna cut its 2025 sales forecast by $1 billion on Monday, hurt by a slow launch of its respiratory syncytial…

Top Stock Movers Now: Moderna, Macys, Valero Energy, and More

U.S. equities were mixed at midday, with the Nasdaq losing more than 1% on worries about future Federal Reserve interest-rate…

Moderna Aktie: Grund zur Neutralität

Die Moderna Aktie zeigt sich zu Beginn des Jahres 2025 in verhaltener Verfassung. Der aktuelle Kurs liegt bei 41,26 EUR,…

Stock Market Roundup 2024: Heres What Worked, What Didnt, and What Stocks Investors Can Buy Now and Hold Forever

The start of a new year is a great time to review what happened over the last 12 months and…

Moderna: Gelingt die Trendwende?

Das Jahr 2024 verlief für die Aktie von Moderna alles andere als erfolgreich. DER AKTIONÄR analysiert, ob dies der Tiefpunkt…

Moderna: Gelingt die Trendwende?

Das Jahr 2024 verlief für die Aktie von Moderna alles andere als erfolgreich. DER AKTIONÄR analysiert, ob dies der Tiefpunkt…

Moderna: Can They Benefit From Bird Flu? (Rating Upgrade)

…

Moderna Aktie: Kurszielsenkung wegen des unsicheren makroökonomischen Umfelds

Zürich (www.aktiencheck.de) - Moderna-Aktienanalyse von der UBS: Aktuelle Bewertung UBS hat das Kursziel für die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN:…

Moderna stock forfeits gains as first US bird flu death puts vaccine development in focus

…

Moderna stock on track for 20% weekly gain after US bird flu death

…

Opening Bell: US-Markt auf Richtungssuche; Bitcoin, Ebay, Moderna, D-Wave, Palantir, Novo Nordisk, Tencent, Cal-Maine Foods & Co.

Zinsen standen gestern im Fokus der Wall Street. Überraschend robuste Konjunkturdaten dämpften die Erwartungen auf Zinssenkungen, was zu Gewinnmitnahmen führte.…

Stocks to Watch Wednesday: Moderna, Nvidia, Shell, Flutter

…

5 Things to Know Before the Stock Market Opens

U.S. stock futures edge lower after a tech selloff yesterday, investors prepare for a halt to trading tomorrow for the…

Why Moderna shares are rallying this week By Investing.com

Why Moderna shares are rallying this week…

Prediction: These Could Be the Best-Performing Value Stocks Through 2030

It might seem that valuation is no longer important for investors. Stocks that have sky-high valuation metrics continue to soar.…

Moderna Price Levels to Watch After Stocks 12% Surge on Tuesday

Moderna shares soared as investors placed bets that the pharmaceutical giant’s development of an H5N1 bird flu vaccine could boost…

NVDA, PLTR, IONQ, MRNA, TSLA: Top 5 Trending Stocks Today - IonQ (NYSE:IONQ), Moderna (NASDAQ:MRNA)

The U.S. stock market experienced a downturn on Tuesday, with the Nasdaq Composite falling by 1.9% and the S&P 500…

Moderna (MRNA) Stock Jumps 11.7%: Will It Continue to Soar?

Moderna (MRNA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate…

Moderna among vaccine makers to surge after US bird flu death

Moderna Inc (NASDAQ:MRNA, ETR:0QF) shares surged alongside rival vaccine makers on Tuesday after news broke of the first human death…

Moderna targets 10 new approvals by 2027 By Investing.com

Moderna targets 10 new approvals by 2027…

Moderna: From Breakthrough COVID-19 Vaccines To Personalized Cancer Therapies

…

Aktie von Moderna heute am Aktienmarkt gefragt (40,50 €)

Im Plus liegt zur Stunde der Anteilsschein von Moderna . Das Papier notiert aktuell bei 40,50 Euro. Freuen können sich…

Moderna: 2025 Contrarian Play

…

Is Moderna Stock a Buy?

Modernas (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The companys revenue, earnings, and stock price…

3 Stocks That Could Turn $1,000 into $5,000 by 2030

A five-bagger in only five years? Any investor would love to buy such a stock. Fortunes can be made quickly…

Moderna Aktie: Downgrade - Rückgang bei COVID-Impfstoffverkäufen belastet

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Argus Research: Rating und Kursziel Die Analysten von Argus haben die Aktie von Moderna Inc. (ISIN:…

Argus downgrades Moderna to hold on weak near-term outlook By Investing.com

Argus downgrades Moderna to hold on weak near-term outlook…

3 No-Brainer Biotech Stocks to Buy With $200 Right Now

Investing in biotech stocks usually isnt for the faint of heart. These stocks tend to be highly volatile because of…

Moderna: Cutting Costs Might Not Be Enough

…

Palantir Stock Retreats, MicroStrategy Rises on News of Nasdaq 100 Addition

Palantir Technologies, MicroStrategy, and Axon Enterprise are set to join the Nasdaq 100 Index on Monday, Dec. 23, replacing Super…

Why I Cant Stop Buying This Ultra-High-Yielding ETF

I love generating passive income. I currently use that income to make more income-generating investments. My goal is to eventually…

INDEX-MONITOR: Moderna fliegt aus Nasdaq 100 - Palantir und MicroStrategy rein

NEW YORK (dpa-AFX) - Der US-Pharmakonzern und Impfstoffhersteller Moderna muss noch vor Weihnachten aus dem technologielastigen US-Aktienindex Nasdaq 100…

MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed

(Bloomberg) -- MicroStrategy Inc., the dot-com-era software maker whose metamorphosis into a leveraged bet on Bitcoin has transfixed Wall Street,…

MicroStrategy, Palantir Added to Nasdaq 100, Moderna Removed

MicroStrategy Inc., the dot-com-era software maker whose metamorphosis into a leveraged bet on Bitcoin has transfixed Wall Street, is joining…